Balanced news tone
News Sentiment
EVGN sentiment intelligence
Evogene news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+19.2% over one week, -12.3% over four weeks, trend inactive, and below fair value.
AgPlenus Launches Antifungal Potency Predictor, Expanding ChemPass AI for Ag Capabilities
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Evogene (EVGN) Edges Lower, Testing Key Support at $0.66 - Motive Wave
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- dars.gov.et
Evogene (EVGN) Edges Lower, Testing Key Support at $0.66 - Zigzag Correction
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- dars.gov.et
Evogene (EVGN) Edges Higher: Modest Uptick Amid Support Level Test - Up Down Volume
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- dars.gov.et
Evogene: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 May 2026 11:06
- Source
- Associated Press
Evogene Reports First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 May 2026 11:00
- Source
- PR Newswire
Evogene Ltd. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- Market source
Earnings call transcript: Evogene reports Q1 2026 loss, stock rises 1.95%
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- Investing.com
Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN)
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Evogene (EVGN) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 01:57
- Source
- Stock Titan
Evogene (EVGN) Stock Forecast and Price Target 2026
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 11 May 2024 16:46
- Source
- MarketBeat
Evogene (EVGN) Stock News & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Sep 2020 12:26
- Source
- Stock Titan